Legato Frames Combine AI Hearing Aids and Prescription Glasses in One Device

Legato Frames Combine AI Hearing Aids and Prescription Glasses in One Device

Legato announced the availability of Legato Frames, eyewear that combines over-the-counter hearing aids with prescription lenses in a single device. The glasses start at $999 and are available online, with plans to expand sales through select eyecare providers nationwide.

Designed for adults with mild-to-moderate hearing loss, Legato Frames place the hearing hardware inside the arms of the glasses rather than using an in-ear device. The company is positioning the product as an alternative for people who want hearing assistance without wearing a conventional hearing aid.

The Frames use Legato’s patented SpeechSense AI technology to separate speech from surrounding noise and enhance voices in real time. Processing takes place directly on the glasses, and Legato says the product does not use cameras or record audio.

An open-ear design keeps the ear canal unobstructed while allowing users to hear amplified speech and remain aware of their surroundings. The glasses also support Bluetooth streaming for phone calls and music on iPhone and Android devices.

Legato is offering the Frames in three styles. One of those, Aria, uses an acetate-and-metal browline design. All three models use Pentax lenses and can accommodate prescription lenses while keeping the hearing components inside the temples.

The Frames weigh as little as 34 grams with lenses and are rated for 10 to 12 hours of battery life. Legato is also including lifetime support from its U.S.-based audiologists and product specialists.

Independent testing cited by the company provides one measure of the product’s hearing performance. HearAdvisor tested Legato Frames in May 2026 and awarded them a SoundScore of 4.6 out of 5. According to Legato, that placed the Frames among the top 10 devices evaluated by the lab across both over-the-counter and prescription hearing aids.

Legato is targeting a large group of adults who have hearing loss but do not use hearing aids. The company said roughly 50 million U.S. adults have recognized hearing loss, while 80% of people who could benefit from hearing aids do not use them. Cost, comfort and stigma are among the barriers the company cited.

Legato also pointed to research connecting hearing-device use with broader health outcomes. A meta-analysis covering more than 126,000 people across eight long-term studies, cited by the 2024 Lancet Commission report on dementia, found that hearing-device users with hearing loss had nearly a 20% lower risk of cognitive decline and a 17% lower risk of dementia than people with hearing loss who did not adopt a hearing solution.

“We started Legato because we fundamentally believe that people deserve better choices for hearing care,” said Mehul Trivedi, CEO and co-founder of Legato. “There are millions of people who want to hear better, but remain on the sidelines because they have not found a product they actually want to wear. We want to change that.”

The product launch follows Legato’s emergence from stealth in August 2026 with $12 million in funding from Neotribe Ventures, Listen and Village Global. The company was founded in 2024 by Trivedi and Steve Romine, both of whom previously worked on hearing and wearable audio products.

Legato Frames are regulated by the FDA as over-the-counter hearing aids for adults with mild-to-moderate hearing loss. The company says the Frames were designed and manufactured to meet applicable FDA requirements covering safety, performance, labeling and consumer protections.

Legato Frames are available now through the company’s website. Legato also plans to sell them through select eyecare providers, where purchases may qualify for vision insurance depending on the applicable plan.

This analysis is based on reporting from GlobeNewswire.

Images courtesy of Legato.

This article was generated with AI assistance and reviewed for accuracy and quality.

Updated Oct 1, 2026

About this article: This article was generated with AI assistance and reviewed by our editorial team to ensure it follows our editorial standards for accuracy and independence. We maintain strict fact-checking protocols and cite all sources.

Word count: 601Reading time: 0 minutes

📧 Stay Updated

Get the latest AI news delivered to your inbox every morning.

AI News Daily

Breaking Intelligence • Since 2023

Join hundreds of thousands of AI professionals who start their day with our curated newsletter. Get breaking news, expert analysis, and exclusive insights.

Stay Ahead of AI

Get the latest AI breakthroughs, tools, and insights delivered to your inbox every week.

✓ Free forever✓ Unsubscribe anytime✓ No spam guarantee

Go Premium

Unlock unlimited AI tools and an ad-free reading experience designed for AI professionals.

• Ad-free experience• Premium AI tools
Start Free Trial

14-day free trial • Cancel anytime
Plus $9/mo • Pro $90/yr (2 months free)

Follow Our Community

ChatAI

Breaking Intelligence

Your daily briefing on what matters in AI. Trusted by developers, researchers, executives, and AI enthusiasts worldwide.

© 2026 ChatAI. All rights reserved.